Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data. Lupin has received approval from the Food and Drug Administration for ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be manufactured at ...

The United States Food and Drug Administration (USFDA) (Image Credits: Reuters) The United States Food and Drug Administration (USFDA) has approved the first generics of Xarelto (rivaroxaban) tablets ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the company’s pharma division was able to eke out modest sales gains of 1.7% in the ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

The NPR Network will be reporting live from Chicago throughout the week bringing you the latest on the Democratic National Convention. Actress Kerry Washington introduced two of Kamala Harris’ ...

Democrats are falling in line to support Vice President Kamala Harris as the party's next presidential nominee after Joe Biden dropped out of the race Sunday. It means you will hear her name said more ...

As she steps further into the spotlight, you’ll be hearing her name said more — both correctly and incorrectly. How do you pronounce Kamala? Kamala Harris’s name is pronounced “COM-mah-lah,” with the ...

LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto ...

PIONEER AF-PCI exploratory trial found that elderly patients experienced a lower rate of clinically significant bleeding after 12 months of treatment with Xarelto (rivaroxaban). Johnson & Johnson has ...

Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "XARELTO Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive ...